Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SPECTRUM PHARMACEUTICALS INC | 317,259 | reported | 16 Mar 2022 | tx 60+2,652,714−289,947 |
| OmniAb, Inc. | 124,584 | reported | 18 Feb 2026 | tx 47+3,264,849−414,449 |
| HALOZYME THERAPEUTICS, INC. | 62,000 | reported | 04 Feb 2013 | tx 13+374,738 |
| Xencor Inc | 20,183 | reported | 16 Jun 2025 | tx 21+199,359−34,496 |
| Niagen Bioscience, Inc. | 20,000 | reported | 17 Jun 2021 | tx 6+140,000 |
| OmniAb, Inc. | 0 | reported | 01 Nov 2022 | tx 4+88,966−88,966 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Feb 2026 | SALE | OmniAb, Inc. | 9,301 | 1.71 USD | |
| 18 Feb 2026 | EXERCISE | OmniAb, Inc. | 18,750 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | OmniAb, Inc. | 60,000 | 0.00 USD | deriv |
| 18 Feb 2026 | EXERCISE | OmniAb, Inc. | 18,750 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | OmniAb, Inc. | 600,000 | 0.00 USD | deriv |
| 17 Feb 2026 | SALE | OmniAb, Inc. | 6,828 | 1.70 USD | |
| 16 Feb 2026 | EXERCISE | OmniAb, Inc. | 13,542 | 0.00 USD | |
| 16 Feb 2026 | EXERCISE | OmniAb, Inc. | 13,542 | 0.00 USD | deriv |
| 08 Dec 2025 | SALE | OmniAb, Inc. | 23,922 | 1.96 USD | |
| 07 Dec 2025 | EXERCISE | OmniAb, Inc. | 46,500 | 0.00 USD | |
| 07 Dec 2025 | EXERCISE | OmniAb, Inc. | 46,500 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Xencor Inc | 13,686 | 0.00 USD | |
| 16 Jun 2025 | SALE | Xencor Inc | 2,993 | 9.22 USD | |
| 12 Jun 2025 | GRANT_AWARD | Xencor Inc | 27,372 | 0.00 USD | deriv |
| 07 Apr 2025 | SALE | OmniAb, Inc. | 7,206 | 2.00 USD | |
| 07 Apr 2025 | EXERCISE | OmniAb, Inc. | 13,542 | 0.00 USD | |
| 07 Apr 2025 | EXERCISE | OmniAb, Inc. | 13,542 | 0.00 USD | deriv |
| 01 Apr 2025 | EXERCISE | OmniAb, Inc. | 23,244 | 0.00 USD | |
| 01 Apr 2025 | SALE | OmniAb, Inc. | 11,963 | 2.37 USD | |
| 01 Apr 2025 | EXERCISE | OmniAb, Inc. | 23,244 | 0.00 USD | deriv |
| 16 Feb 2025 | EXERCISE | OmniAb, Inc. | 13,541 | 0.00 USD | |
| 19 Feb 2025 | SALE | OmniAb, Inc. | 7,255 | 3.67 USD | |
| 18 Feb 2025 | GRANT_AWARD | OmniAb, Inc. | 337,500 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | OmniAb, Inc. | 56,250 | 0.00 USD | deriv |
| 16 Feb 2025 | EXERCISE | OmniAb, Inc. | 13,541 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 28 Nov 2022.